tradmap

ROIV Earnings Roivant Sciences Ltd.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$1 $2 $5 $0 2022 2023 2024 2025 2026
EPS
Revenue (annual)
$0 $28M $55M 2021 2022 2023 2024 2025 2026
Revenue
Net income (annual)
-$1B $2B $4B $0 2021 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 $3 $6 $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
EPS
Revenue (quarterly)
$0 $8M $16M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$304M $2B $5B $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–26 of 26
Q1 20262026-06-30-0.262026-08-0610-Q
Q4 2025 (derived)2026-03-310.342026-05-2010-K
FY 20252026-03-31-0.542026-05-2010-K
Q3 20252025-12-31-0.382026-02-0610-Q
Q2 20252025-09-30-0.172025-11-1010-Q
Q1 20252025-06-30-0.332025-08-1110-Q
Q4 2024 (derived)2025-03-31-0.282025-05-2910-K
FY 20242025-03-31-0.242025-05-2910-K
Q3 20242024-12-310.232025-02-1010-Q
Q2 20242024-09-30-0.312024-11-1210-Q
Q1 20242024-06-300.122024-08-0910-Q
Q4 2023 (derived)2024-03-31-0.022024-05-3010-K
FY 20232024-03-315.232024-05-3010-K
Q3 20232023-12-316.032024-02-1310-Q
Q2 20232023-09-30-0.402023-11-1310-Q
Q1 20232023-06-30-0.382023-08-1410-Q
Q4 2022 (derived)2023-03-31-0.032023-06-2810-K
FY 20232023-03-31-1.422023-06-2810-K
Q3 20222022-12-31-0.492023-02-1310-Q
Q2 20222022-09-30-0.422022-11-1410-Q
Q1 20222022-06-30-0.482022-08-1510-Q
Q4 2021 (derived)2022-03-31-0.40——
FY 20222022-03-31-1.26——
Q3 20212021-12-31-0.41——
Q2 20212021-09-30-0.32——
Q1 20212021-06-30-0.13——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.